Iguana Healthcare Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Iguana Healthcare Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.02M	Buy	100,000 +50,000	+100%	+$1.17M	1.33%	33
2017 Q4	$1M	Sell	50,000 -10,000	-17%	-$197K	0.65%	46
2017 Q3	$1.24M	Sell	60,000 -15,000	-20%	-$254K	0.68%	48
2017 Q2	$1.11M	Hold	75,000	–	–	0.63%	48
2017 Q1	$1.2M	Buy	75,000 +25,000	+50%	+$361K	0.59%	52
2016 Q4	$630K	Buy	+50,000	New	+$931K	0.38%	51

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Iguana Healthcare Management's DPLO Position: Q1 2018 in Review

Iguana Healthcare Management increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 100% in Q1 2018, buying an estimated $1.17M and bringing the position to 100,000 shares worth $2.02M. The position accounts for 1.33% of the portfolio, ranked #33.

Iguana Healthcare Management first reported a position in DPLO in Q4 2016 and has held it in 6 quarters since. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

Iguana Healthcare Management held 100,000 shares of DIPLOMAT PHARMACY, INC. worth $2.02M as of Q1 2018.
Iguana Healthcare Management bought 50,000 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $1.17M.
DIPLOMAT PHARMACY, INC. made up 1.33% of Iguana Healthcare Management's portfolio in Q1 2018, its #33 holding.
Iguana Healthcare Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and has held it in 6 quarters since.
201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.